CMS approves New Hampshire to impose Medicaid work requirements

New Hampshire will become the fourth state to impose work requirements on Medicaid beneficiaries, according to a May 7 joint statement from CMS, HHS and New Hampshire Governor Chris Sununu.

New Hampshire, which expanding Medicaid in 2014 under the Affordable Care Act (ACA) to cover those making up to 138 percent of the federal poverty level, will require those between 19 and 64 years old to participate in 100 hours of activity—including work, school, job training and community service—each month. Exemptions will be available for some populations, including some elderly, parents and medically at-risk individuals.

"Work requirements help lift able-bodied individuals out of poverty by empowering them with the dignity of work and self-reliability while also allowing states to control the costs of their Medicaid programs. They help people gain the skills necessary for long-term independence and success,” New Hampshire’s Republican Gov. Governor Chris Sununu said in a statement.

New Hampshire is the fourth state to implement such requirements after the Trump administration, following Kentucky, Indiana and Arkansas, all of which expanded Medicaid coverage under the ACA. Six states are currently applying for the ability to implement such work requirements.

“I congratulate Governor Sununu’s commitment to join me in improving the lives of Medicaid beneficiaries by creating a crucial link to work and community engagement,” CMS administrator Seema Verma, MPH, said in the joint statement.

Back when such work requirements were announced, American College of Physicians (ACP) president Jack Ende, MD, said this new policy will restrict Medicaid eligibility.

“Medicaid was designed as a healthcare program, to provide vulnerable members of our society with access to care they badly need,” Ende wrote. “Work requirements impose an additional, unnecessary barrier to allowing patients access to vital health care services for people who need access and coverage the most.”

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.